Kinase inhibitors
US7528132B2 · kind B2 · utility
12Cited by
0References
35Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 24, 2006 |
| Grant date | May 5, 2009 |
| Priority date | — |
| Expiry date | Dec 7, 2026 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A compound having the general structure of Formula (I):or a pharmaceutically acceptable salt, solvate, or ester thereof, are useful in treating diseases, disorders, or conditions such as immunodeficiencies, cancers, cardiovascular diseases, endocrine disorders, Parkinson's disease, metabolic diseases, tumorigenesis, Alzheimer's disease, heart disease, diabetes, neurodegeneration, inflammation, kidney disease, atherosclerosis and airway disease.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.